IBIO

Conviction 18HealthcareScan · Mon, Aug 10, 2026

IBIO$1.40-1.06%

ResistanceSupportVol 14

Vol MA14 649.79K

May 11May 28Jun 16Jul 6Jul 23Aug 10

iBio, Inc.PHARMACEUTICAL PREPARATIONSwww.ibioinc.com ↗

Price1.40

Change-1.06%

Gap+0.00%

Rel volume1.29×

Avg volume702.13K

Avg $ vol985.45K

SMA 201.40

SMA 501.57

SMA 2001.84

Price vs 50-11.21%

Price vs 200-24.09%

MA stackbearish

50/200 cross—

Supertrenddown · 1.66

RSI (14)43

MACD hist0.01

MACD cross—

Stoch %K / %D53 / 54

ADX (14)9

+DI / −DI18 / 20

RSI divergence—

MACD divergence—

ATR %+6.57%

ADR %6.25%

52w high3.07

52w low0.5731

From 52w high-54.56%

Above 52w low+143.41%

New 52w highNo

SqueezeOn · 7d

Bollinger width8.08%

%B0.43

Donchian pos53.49%

Donchian high1.50

Donchian low1.28

AVWAP (52w high)2.26

vs AVWAP high-38.29%

AVWAP (52w low)1.81

vs AVWAP low-23.04%

OBV trendFlat

Chaikin MF (20)-0.00

Today vs 20d1.29×

Avg vol (14d)649.79K

Avg vol (20d)702.13K

Avg $ vol (20d)985.45K

Market cap69.3M

RS 3m (vs SPY)-19.72%

RS 6m (vs SPY)-48.53%

RS line new highNo

Trend template3/8

Technical rank12.9

1 week-1.76%

1 month-7.62%

3 months-18.42%

6 months-42.36%

1 year+134.69%

YTD-30.94%

P/E-3.77

P/B0.89

P/S173.25

P/FCF-4.52

EPS-1.75

Div yield—

ROE-23.70%

ROA-21.41%

Debt/Eq—

Current11.88

EV/EBITDA-1.18

Gross margin541.75%

Net margin—

Rev growth77.78%

EPS growth26.22%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value21.67M

Revenue0

Net income-7.73M

Gross profit1.9M

Free cash flow-15.32M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out49.68M

Employees20

ListedTue, Aug 19, 2008

Free float31.53M

Float %91.3%

Short interest5.38M

Days to cover4.0d

Short volume46.4%

Squeeze score63 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction18 / 100

Pattern quality—

Tech rank12.9 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.94

Support1.29

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IBIO

All disclosures →

No recent disclosed trades by Congress in IBIO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IBIO · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Stoner Elizabeth Director · Stock Option (right to buy) · 2026-05-18	Grant	60K	$0	2026-05-18	2026-05-19

SEC filings

EDGAR filings in IBIO · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.